Atossa Therapeutics, Inc. (ATOS)

CIK 1488039 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Atossa Therapeutics, Inc..

Recent SEC filings

FiledFormAccession number
Aug 7, 202610-Q0001193125-26-339257
Aug 7, 20268-K0001193125-26-339292
Jun 12, 2026424B50001193125-26-268597
Jun 11, 20268-K0001193125-26-266717
May 14, 202640001193125-26-224133
May 14, 202640001193125-26-224125
May 14, 202640001193125-26-224140
May 14, 202640001193125-26-224135
May 14, 202640001193125-26-224148
May 14, 202640001193125-26-224521
May 8, 20268-K0001193125-26-213439
May 8, 20268-K0001193125-26-213373
May 8, 202610-Q0001193125-26-213423
Apr 16, 20268-K0001193125-26-158030
Mar 31, 202640001193125-26-134861
Mar 30, 202640001193125-26-132644
Mar 30, 2026ARS0001193125-26-131954
Mar 30, 2026DEF 14A0001193125-26-131807
Mar 25, 20268-K0001193125-26-124393
Mar 25, 202610-K0001193125-26-124396
Mar 20, 2026PRE 14A0001193125-26-117826
Feb 20, 2026424B50001193125-26-061388
Feb 20, 20268-K0001193125-26-061412
Feb 20, 2026424B30001193125-26-061342
Feb 17, 20268-K0001193125-26-054797